Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × OTHER_GOV × Dermatologic × Clear all

Phase

Status

Completed 16 Unknown 11 Recruiting 7 Not yet recruiting 4 Withdrawn 2 Terminated 1 Suspended 1 Enrolling by invitation 1 Active not recruiting 1

Sponsor Class

OTHER 278 INDUSTRY 211 NIH 53 NETWORK 15 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 12 Breast 7 Lymphoid 6 Thoracic 5 Genitourinary 5 Other hematologic neoplasm 3 Head & Neck 3 Sarcoma 2 Plasma cell 1 Other solid neoplasm 1 Other 1 Gynecologic 1 Dermatologic 1 CNS 1

Conditions

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04924413 2024-07-03

L-TIL Plus Tislelizumab as First-line Treatment in Advanced Malignant Melanoma

Henan Cancer Hospital

Phase 2 Terminated

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡